VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NIVFW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NIVFWNewGenIvf Group Limited
$0.04$20588
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNIVFWQuarterly Financials

NewGenIvf Group Limited (NIVFW) Quarterly Financials

120+ quarters historyFree accessUpdated daily

NewGenIvf Group Limited (NIVFW) quarterly income statement — complete revenue, gross profit & net income history

NIVFW Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'24Q4'23Q3'23Q4'22
Sales/Revenue1.27M1.52M00
Revenue Growth %-16.18%---
Cost of Goods Sold734.48K1.32M00
COGS % of Revenue57.67%87.05%--
Gross Profit539.13K196.82K00
Gross Margin %42.33%12.95%--
Gross Profit Growth %173.92%---
Operating Expenses1.63M1.27M377.72K115.64K
OpEx % of Revenue127.85%83.32%--
Selling, General & Admin1.63M1.27M377.72K115.64K
SG&A % of Revenue127.85%83.32%--
Research & Development0000
R&D % of Revenue----
Other Operating Expenses0000
Operating Income-1.09M-1.27M-377.72K-115.64K
Operating Margin %-85.51%-83.32%--
Operating Income Growth %13.97%-994.8%--
EBITDA-909.22K-1.1M127.02K474.36K
EBITDA Margin %-71.39%-72.33%--
EBITDA Growth %17.27%-331.69%--
D&A (Non-Cash Add-back)179.9K166.95K00
EBIT-121.58K284.9K127.02K474.36K
Net Interest Income-417K-25.14K504.74K590K
Interest Income4.55K122504.74K590K
Interest Expense421.11K25.26K00
Other Income/Expense546.44K310.85K504.74K590K
Pretax Income-543K-955K127.02K474.36K
Pretax Margin %-42.63%-62.85%--
Income Tax-487K000
Effective Tax Rate %89.69%0%0%0%
Net Income-108K-955K127.02K474.36K
Net Margin %-8.48%-62.85%--
Net Income Growth %88.69%-301.32%--
Net Income (Continuing)-55.98K-955K127.02K474.36K
Discontinued Operations0000
Minority Interest-433.14K-490.05K0-462.43K
EPS (Diluted)-4.6031.9822.6952.79
EPS Growth %-114.37%-39.41%--
EPS (Basic)-4.6031.9822.6952.79
Diluted Shares Outstanding588.24K262.19K262.19K262.19K
Basic Shares Outstanding588.24K262.19K262.19K262.19K
Dividend Payout Ratio----